Loading markets…

Arrowhead Pharmaceuticals, Inc. (ARWR) forecast

Arrowhead Pharmaceuticals, Inc. (ARWR) forecast: price $57.66, trailing P/E -26.27, forward P/E 13.09. How to read the street's path.

$57.66Price
$8.14BMarket cap
-26.27P/E ?
13.09Forward P/E ?
0.00%Dividend yield ?

The live ARWR price is $57.66. Trailing P/E is -26.27 and forward P/E is 13.09. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the ARWR forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full ARWR quote · Dividends · Price prediction · Academy

Questions

What is ARWR's forward P/E?

The latest forward P/E on Stocklytics is 13.09, against a trailing P/E of -26.27 and a price of $57.66.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.